AQR Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $43.8M | Sell |
|
|||||
|
2021
Q1 | $40.9M | Sell |
|
|||||
|
2020
Q4 | $58.6M | Sell |
|
|||||
|
2020
Q3 | $214M | Sell |
|
|||||
|
2020
Q2 | $235M | Sell |
|
|||||
|
2020
Q1 | $237M | Buy |
|
|||||
|
2019
Q4 | $255M | Buy |
|
|||||
|
2019
Q3 | $138M | Buy |
|
|||||
|
2019
Q2 | $140M | Sell |
|
|||||
|
2019
Q1 | $214M | Buy |
|
|||||
|
2018
Q4 | $68.8M | Buy |
|
|||||
|
2018
Q3 | $35M | Sell |
|
|||||
|
2018
Q2 | $40.8M | Sell |
|
|||||
|
2018
Q1 | $84.8M | Sell |
|
|||||
|
2017
Q4 | $167M | Buy |
|
|||||
|
2017
Q3 | $132M | Buy |
|
|||||
|
2017
Q2 | $40M | Buy |
|
|||||
|
2017
Q1 | $7.72M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.79M | Buy |
|
|||||
|
2016
Q2 | $631K | Sell |
|
|||||
|
2016
Q1 | $1.36M | Sell |
|
|||||
|
2015
Q4 | $1.92M | Sell |
|
|||||
|
2015
Q3 | $10.2M | Sell |
|
|||||
|
2015
Q2 | $38.2M | Sell |
|
|||||
|
2015
Q1 | $58.8M | Sell |
|
|||||
|
2014
Q4 | $136M | Sell |
|
|||||
|
2014
Q3 | $125M | Buy |
|
|||||
|
2014
Q2 | $86.4M | Buy |
|
|||||
|
2014
Q1 | $46M | Buy |
|
|||||
|
2013
Q4 | $7M | Buy |
|
|||||
|
2013
Q3 | $4.13M | Buy |
|
|||||
|
2013
Q2 | $2.08M | Buy |
|